Outcome of 3rd Implementation and Monitoring Committee meeting has been attached herewith.
Outcome Of 3Rd Monitoring Committee Meeting Of Dharti Proteins Limited (Formerly Known As Devika Proteins Limited) Held On 27Th April, 2026
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Dharti Proteins Ltd on 6ix
Story so far
Earlier from Dharti Proteins
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Closure of Trading Window
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Results - Financial Results For December 31, 2025
Later from Dharti Proteins
- Reg. 34 (1) Annual Report.
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On Friday, May 29, 2025.
- Intimation Of Listing Approval Received From BSE Limited For 5,00,000 Equity Shares Of Rs. 10/- Each.
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Change In ISIN Pursuant To Approved Resolution Plan Under CIRP
Follow Dharti Proteins into a list and get an email when it puts out news.
Follow Dharti Proteins